U.S. panel rejects Sanofi obesity drug
115232
SILVER SPRING, Maryland  - U.S. regulators should reject a proposed weight-loss pill called Zimulti because of concerns it may increase suicidal thinking and depression, an advisory panel unanimously said on Wednesday.
22799
A U.S. panel of medical experts recommended on Friday that U.S. regulators reject AstraZeneca's   application to sell its anti-clotting drug Exanta.
707710
US medical experts on Wednesday voted unanimously against recommending approval of Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc.
687565
NEW YORK - A US Food and Drug Administration advisory panel rejected Procter &amp; Gamble&#39;s testosterone patch to treat female sexual dysfunction.
701126
Sanofi-Aventis said on Friday it was  withdrawing its application to sell obesity drug rimonabant --  its biggest new drug hope -- in the United States.
676787
Description: A government task force is recommending against allowing people to import prescription drugs from other nations. The task force says it would be exceedingly difficult to guarantee that drugs imported
343005
A regulatory panel&#39;s Thursday decision not to recommend approval of Proctor &amp; Gamble Co.&#39;s sex-drive patch for women slammed shares of BioSante Pharmaceuticals Inc.
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
278822
A weight loss drug used widely in the UK is rejected by US safety officials over fears of an increased suicide risk.
629901
Sept. 30, 2004 -- Sweeping changes are needed in America to prevent the growing childhood obesity epidemic from wreaking havoc on the nation&#39;s overall health and its medical system, concludes an Institute of Medicine panel.
684651
SILVER SPRING, Maryland  - The Sanofi-Aventis antibiotic Ketek is safe enough to stay on the market for treating pneumonia, but regulators should withdraw approval for bronchitis and sinusitis, a U.S. advisory panel said on Friday.
579771
Panel stops short of calling for rigorous measures to tackle eating disorders.
494299
Sanofi-Aventis expects to get a decision from U.S. regulators by April 26 on whether it may sell anti-obesity pill and potential blockbuster Acomplia in the world's largest drug market, following a six-month review.
275903
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell a cholesterol-lowering drug without  a prescription.
35338
A new report by a national health advocacy group calls state and national policies ineffective tools in the war against obesity. The Trust for America&#39;s Health, a nonprofit organization based
582851
A panel of experts will meet on Tuesday to consider whether the Food and Drug Administration should approve Sanofi-Aventis' experimental bird flu vaccine, which could become the first such product cleared for the U.S. market.
210343
A prominent study by the U.S. Centers  for Disease Control and Prevention may have overstated the  number of obesity-related deaths in 2000 by as much as 20  percent, The Wall Street Journal reported on Tuesday.